SPC Financial Inc’s AstraZeneca AZN Stock Holding History

SPC Financial Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,750	Closed	-$250K	–	209
2023 Q2	$250K	Sell	1,750 -300	-15%	-$44.1K	0.03%	197
2023 Q1	$285K	Sell	2,050 -200	-9%	-$26.9K	0.03%	176
2022 Q4	$305K	Sell	2,250 -300	-12%	-$37.6K	0.04%	160
2022 Q3	$280K	Sell	2,550 -400	-14%	-$50.7K	0.03%	158
2022 Q2	$390K	Sell	2,950 -300	-9%	-$39.4K	0.05%	142
2022 Q1	$431K	Sell	3,250 -300	-8%	-$36K	0.05%	135
2021 Q4	$414K	Sell	3,550 -300	-8%	-$35.3K	0.05%	136
2021 Q3	$462K	Buy	+3,850	New	+$448K	0.06%	118
2014 Q3	–	Sell	-6,550	Closed	-$487K	–	106
2014 Q2	$487K	Buy	+6,550	New	+$474K	0.14%	79

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SPC Financial Inc's AZN Position: Q3 2023 in Review

SPC Financial Inc sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 1,750 shares — an estimated $250K sold.

SPC Financial Inc first reported a position in AZN in Q2 2014 and held it in 9 quarters. The position peaked at $487K in Q2 2014. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

SPC Financial Inc reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
SPC Financial Inc sold 1,750 AstraZeneca shares in Q3 2023, an estimated $250K.
SPC Financial Inc first reported a position in AstraZeneca in Q2 2014 and held it in 9 quarters.
SPC Financial Inc's AstraZeneca position peaked at $487K in Q2 2014.
1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on SPC Financial Inc's 13F filing for Q3 2023, filed 9 Nov 2023.